Cargando…

In vitro NTPase activity of highly purified Pdr5, a major yeast ABC multidrug transporter

The ABC transporter Pdr5 of S. cerevisiae is a key player of the PDR network that works as a first line of defense against a wide range of xenobiotic compounds. As the first discovered member of the family of asymmetric PDR ABC transporters, extensive studies have been carried out to elucidate the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Manuel, Smits, Sander H. J., Schmitt, Lutz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533308/
https://www.ncbi.nlm.nih.gov/pubmed/31123301
http://dx.doi.org/10.1038/s41598-019-44327-8
_version_ 1783421172487028736
author Wagner, Manuel
Smits, Sander H. J.
Schmitt, Lutz
author_facet Wagner, Manuel
Smits, Sander H. J.
Schmitt, Lutz
author_sort Wagner, Manuel
collection PubMed
description The ABC transporter Pdr5 of S. cerevisiae is a key player of the PDR network that works as a first line of defense against a wide range of xenobiotic compounds. As the first discovered member of the family of asymmetric PDR ABC transporters, extensive studies have been carried out to elucidate the molecular mechanism of drug efflux and the details of the catalytic cycle. Pdr5 turned out to be an excellent model system to study functional and structural characteristics of asymmetric, uncoupled ABC transporters. However, to date studies have been limited to in vivo or plasma membrane systems, as it was not possible to isolate Pdr5 in a functional state. Here, we describe the solubilization and purification of Pdr5 to homogeneity in a functional state as confirmed by in vitro assays. The ATPase deficient Pdr5 E1036Q mutant was used as a control and proves that detergent-purified wild-type Pdr5 is functional resembling in its activity the one in its physiological environment. Finally, we show that the isolated active Pdr5 is monomeric in solution. Taken together, our results described in this study will enable a variety of functional investigations on Pdr5 required to determine molecular mechanism of this asymmetric ABC transporter.
format Online
Article
Text
id pubmed-6533308
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-65333082019-06-03 In vitro NTPase activity of highly purified Pdr5, a major yeast ABC multidrug transporter Wagner, Manuel Smits, Sander H. J. Schmitt, Lutz Sci Rep Article The ABC transporter Pdr5 of S. cerevisiae is a key player of the PDR network that works as a first line of defense against a wide range of xenobiotic compounds. As the first discovered member of the family of asymmetric PDR ABC transporters, extensive studies have been carried out to elucidate the molecular mechanism of drug efflux and the details of the catalytic cycle. Pdr5 turned out to be an excellent model system to study functional and structural characteristics of asymmetric, uncoupled ABC transporters. However, to date studies have been limited to in vivo or plasma membrane systems, as it was not possible to isolate Pdr5 in a functional state. Here, we describe the solubilization and purification of Pdr5 to homogeneity in a functional state as confirmed by in vitro assays. The ATPase deficient Pdr5 E1036Q mutant was used as a control and proves that detergent-purified wild-type Pdr5 is functional resembling in its activity the one in its physiological environment. Finally, we show that the isolated active Pdr5 is monomeric in solution. Taken together, our results described in this study will enable a variety of functional investigations on Pdr5 required to determine molecular mechanism of this asymmetric ABC transporter. Nature Publishing Group UK 2019-05-23 /pmc/articles/PMC6533308/ /pubmed/31123301 http://dx.doi.org/10.1038/s41598-019-44327-8 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Wagner, Manuel
Smits, Sander H. J.
Schmitt, Lutz
In vitro NTPase activity of highly purified Pdr5, a major yeast ABC multidrug transporter
title In vitro NTPase activity of highly purified Pdr5, a major yeast ABC multidrug transporter
title_full In vitro NTPase activity of highly purified Pdr5, a major yeast ABC multidrug transporter
title_fullStr In vitro NTPase activity of highly purified Pdr5, a major yeast ABC multidrug transporter
title_full_unstemmed In vitro NTPase activity of highly purified Pdr5, a major yeast ABC multidrug transporter
title_short In vitro NTPase activity of highly purified Pdr5, a major yeast ABC multidrug transporter
title_sort in vitro ntpase activity of highly purified pdr5, a major yeast abc multidrug transporter
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533308/
https://www.ncbi.nlm.nih.gov/pubmed/31123301
http://dx.doi.org/10.1038/s41598-019-44327-8
work_keys_str_mv AT wagnermanuel invitrontpaseactivityofhighlypurifiedpdr5amajoryeastabcmultidrugtransporter
AT smitssanderhj invitrontpaseactivityofhighlypurifiedpdr5amajoryeastabcmultidrugtransporter
AT schmittlutz invitrontpaseactivityofhighlypurifiedpdr5amajoryeastabcmultidrugtransporter